Madrigal Pharmaceuticals (MDGL) Return on Sales (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) posted quarterly Return on Sales of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and up 47.08% quarter-over-quarter from 0.0% in Q1 2026.
Madrigal Pharmaceuticals (MDGL) Return on Sales (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported Return on Sales for 7 consecutive years, with 0.0% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Jun 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, up 4.0% from the prior year.
- Return on Sales rose to 0.0% in Q2 2026 per MDGL's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q2 2026 and bottomed at 0.1% in Q2 2024.
- Historically, Return on Sales has averaged 0.02% across 3 years, with a median of 0.0% in 2024.
- On a YoY basis, Return on Sales climbed as much as 10 bps in 2025 and fell as far as 0 bps in 2025.
- Madrigal Pharmaceuticals' Return on Sales stood at 0.0% in 2024, then fell by 21 bps to 0.01% in 2025, then jumped by 71 bps to 0.0% in 2026.
- Business Quant data shows MDGL's Return on Sales at 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.01% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.10% |
| Dec 31, 2013 | -5.91% |
| Sep 30, 2013 | -8.60% |
| Jun 30, 2013 | -6.25% |
| Sep 30, 2012 | -3.03% |
| Jun 30, 2012 | -2.01% |
| Mar 31, 2012 | -1.02% |
| Dec 31, 2011 | -0.91% |
| Sep 30, 2011 | -0.08% |
| Jun 30, 2011 | -0.59% |
| Mar 31, 2011 | -0.10% |
| Dec 31, 2010 | -0.02% |